• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

里程碑式文章,1915年6月19日。甲状腺中含碘化合物的结晶形式分离。其化学性质和生理活性。作者E.C. 肯德尔。

Landmark article, June 19, 1915. The isolation in crystalline form of the compound containing iodin, which occurs in the thyroid. Its chemical nature and physiologic activity. By E.C. Kendall.

作者信息

Kendall E C

出版信息

JAMA. 1983 Oct 21;250(15):2045-6.

PMID:6352971
Abstract

By an alkaline alcoholic hydrolysis, the thyroid proteins are broken into many simpler constituents. These may be separated into two groups: the acid insoluble compounds are designated Group A; those acid soluble, Group B. From Group A a pure crystalline compound, containing 60 per cent of iodin, has been isolated. It appears to be di-iodo-di-hydroxy-indol. Group B contains iodin in some unknown form of combination. It is a mixture containing amino-acid complexes and a low molecular weight. Administration of A produces in the dog and in the human being a rapid increase in pulse rate and vigor, and increase in metabolism and nervous irritability. This physiologic activity is produced by the compound containing iodin in all stages of purity up to and including its crystalline form. Given in excess, toxic symptoms are produced. The amount of the iodin compound required to produce toxic effects is exceedingly small. In exophthalmic goiter two abnormal conditions exist. First, the secreting capacity of the gland is greatly increased and, second, the reservoir capacity of the gland is greatly decreased. The iodin compound plays an important role in the production of the symptoms of exophthalmic goiter. The constituents of Group B produce no toxic symptoms, but in cases of cretinism, myxedema and certain skin conditions, they exert physiologic activity.

摘要

通过碱性酒精水解,甲状腺蛋白被分解成许多更简单的成分。这些成分可分为两组:酸不溶性化合物被指定为A组;酸溶性化合物为B组。从A组中分离出一种纯结晶化合物,含碘量为60%。它似乎是二碘二羟基吲哚。B组含有某种未知结合形式的碘。它是一种含有氨基酸复合物和低分子量的混合物。给狗和人服用A会使脉搏率和活力迅速增加,新陈代谢和神经兴奋性增强。这种生理活性在该含碘化合物的所有纯度阶段直至其结晶形式都能产生。过量服用会产生毒性症状。产生毒性作用所需的碘化合物量极少。在突眼性甲状腺肿中存在两种异常情况。第一,腺体的分泌能力大大增强,第二,腺体的储存能力大大降低。碘化合物在突眼性甲状腺肿症状的产生中起重要作用。B组成分不产生毒性症状,但在克汀病、黏液性水肿和某些皮肤病病例中,它们发挥生理活性。

相似文献

1
Landmark article, June 19, 1915. The isolation in crystalline form of the compound containing iodin, which occurs in the thyroid. Its chemical nature and physiologic activity. By E.C. Kendall.里程碑式文章,1915年6月19日。甲状腺中含碘化合物的结晶形式分离。其化学性质和生理活性。作者E.C. 肯德尔。
JAMA. 1983 Oct 21;250(15):2045-6.
2
The isolation of thyroxine (Edward C Kendall).甲状腺素的分离(爱德华·C·肯德尔)
JAMA. 1983 Oct 21;250(15):2047-8.
3
NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).柳氮磺胺吡啶(CAS编号:599-79-1)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1997 May;457:1-327.
4
NTP Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS: 96-45-7) in F344 Rats and B6C3F1 Mice (Feed Studies).NTP对F344大鼠和B6C3F1小鼠进行的乙硫脲(CAS:96-45-7)毒理学和致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1992 Mar;388:1-256.
5
Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).3,3',4,4',5-五氯联苯(PCB 126)(化学物质登记号:57465-28-8)与2,3',4,4',5-五氯联苯(PCB 118)(化学物质登记号:31508-00-6)二元混合物对雌性哈兰·斯普拉格-道利大鼠的毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2006 Nov(531):1-218.
6
NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).国家毒理学计划关于2,2',4,4',5,5'-六氯联苯(多氯联苯153)(化学物质登记号:35065-27-1)对雌性哈兰·斯普拉格-道利大鼠毒理学及致癌性研究的技术报告(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2006 May(529):4-168.
7
Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins.第30章:主要神经维生素缺乏症的历史概况:水溶性B族维生素
Handb Clin Neurol. 2010;95:445-76. doi: 10.1016/S0072-9752(08)02130-1.
8
Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).2,3,7,8-四氯二苯并-对-二噁英(TCDD)(化学物质登记号1746-01-6)、2,3,4,7,8-五氯二苯并呋喃(PeCDF)(化学物质登记号57117-31-4)和3,3',4,4',5-五氯联苯(多氯联苯126)(化学物质登记号57465-28-8)混合物对雌性Harlan Sprague-Dawley大鼠的毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2006 Sep(526):1-180.
9
NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).3,3',4,4',5-五氯联苯(PCB 126)(化学物质登记号:57465-28-8)对雌性哈兰斯普拉格-道利大鼠的NTP毒理学与致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2006 Jan(520):4-246.
10
Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).3,3',4,4',5-五氯联苯(PCB 126)(化学物质登记号:57465-28-8)与2,2',4,4',5,5'-六氯联苯(PCB 153)(化学物质登记号:35065-27-1)二元混合物对雌性哈兰·斯普拉格-道利大鼠的毒理学及致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2006 Aug(530):1-258.

引用本文的文献

1
Amphibians and their impact on human reproduction research.两栖动物及其对人类生殖研究的影响。
F S Rep. 2025 Apr 15;6(Suppl 1):3-6. doi: 10.1016/j.xfre.2025.01.005. eCollection 2025 Apr.
2
Nuclear Receptors and the Hidden Language of the Metabolome.核受体与代谢组学的“隐语”
Cells. 2024 Jul 31;13(15):1284. doi: 10.3390/cells13151284.
3
Metabolic Messengers: Thyroid Hormones.代谢信使:甲状腺激素。
Nat Metab. 2024 Apr;6(4):639-650. doi: 10.1038/s42255-024-00986-0. Epub 2024 Apr 26.
4
Use of levothyroxine in the management of hypothyroidism: A historical perspective.左甲状腺素在甲状腺功能减退症治疗中的应用:历史视角。
Front Endocrinol (Lausanne). 2022 Nov 2;13:1054983. doi: 10.3389/fendo.2022.1054983. eCollection 2022.
5
From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics.从激素替代疗法到再生支架:当前和新型原发性甲状腺功能减退症治疗方法的综述。
Front Endocrinol (Lausanne). 2022 Oct 5;13:997288. doi: 10.3389/fendo.2022.997288. eCollection 2022.
6
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology.肾上腺研究史:从古代解剖学到当代分子生物学。
Endocr Rev. 2023 Jan 12;44(1):70-116. doi: 10.1210/endrev/bnac019.
7
Involvement of Thyroid Hormones in Brain Development and Cancer.甲状腺激素在脑发育和癌症中的作用。
Cancers (Basel). 2021 May 30;13(11):2693. doi: 10.3390/cancers13112693.
8
L-T4 Therapy in Enteric Malabsorptive Disorders.肠吸收不良性疾病的 L-T4 治疗。
Front Endocrinol (Lausanne). 2021 Feb 23;12:626371. doi: 10.3389/fendo.2021.626371. eCollection 2021.
9
Celebrating eighty years of radionuclide therapy and the work of Saul Hertz.庆祝放射性核素治疗 80 周年和 Saul Hertz 的工作。
J Appl Clin Med Phys. 2021 Jan;22(1):4-10. doi: 10.1002/acm2.13175.
10
Nuclear Hormone Receptors and Their Ligands: Metabolites in Control of Transcription.核激素受体及其配体:代谢物在转录控制中的作用。
Cells. 2020 Dec 4;9(12):2606. doi: 10.3390/cells9122606.